Literature DB >> 10986339

Cocaine- and alcohol-mediated expression of inducible transcription factors is blocked by pentobarbital anesthesia.

A E Ryabinin1, Y M Wang, R K Bachtell, A E Kinney, M C Grubb, G P Mark.   

Abstract

Identifying the neurocircuitry involved in behavioral responses to drugs of abuse is an important step towards understanding the mechanisms of drug addiction. The present study sought to distinguish brain regions involved in pharmacological effects of cocaine and ethanol from secondary effects by administering these drugs in the presence or absence of pentobarbital anesthesia. Changes in neuronal activity were assessed by immunohistochemical analysis of expression of an inducible transcription factor (ITF), c-Fos, in the brain of rats habituated to repeated pentobarbital anesthesia or saline administration. Cocaine administration (15 mg/kg, i.v.) in non-anesthetized animals produced a strong induction of c-Fos in the striatum and large number of other brain areas. Ethanol administration (2 g/kg, i.p.) induced c-Fos in a smaller number of characteristic brain areas, including the central nucleus of amygdala and paraventricular nucleus of hypothalamus. However, neither of these drugs was able to induce c-Fos in pentobarbital-anesthetized rats (50 mg/kg, i.v.). The suppressive effects of pentobarbital were not specific to c-Fos, such that pentobarbital also suppressed expression of ITFs FosB and Egr1 in the striatum of cocaine-treated rats. On the other hand, pentobarbital by itself strongly induced c-Fos expression in the lateral habenula of saline-, cocaine-, and ethanol-injected rats. It is not clear whether the suppressive effects of anesthesia on ITF expression in other areas are mediated by activation of lateral habenula, or are independent of this event. Our data suggest that in the absence of conscious awareness of drug-associated cues, cocaine and alcohol activate only a fraction of the neural elements engaged in the unanesthetized state.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10986339     DOI: 10.1016/s0006-8993(00)02681-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Region-specific effects of isoflurane anesthesia on Fos immunoreactivity in response to intravenous cocaine challenge in rats with a history of repeated cocaine administration.

Authors:  Peter R Kufahl; Natalie A Peartree; Krista L Heintzelman; Maggie Chung; Janet L Neisewander
Journal:  Brain Res       Date:  2014-10-22       Impact factor: 3.252

Review 2.  Using c-fos to study neuronal ensembles in corticostriatal circuitry of addiction.

Authors:  Fabio C Cruz; F Javier Rubio; Bruce T Hope
Journal:  Brain Res       Date:  2014-11-11       Impact factor: 3.252

3.  Acute ethanol disrupts photic and serotonergic circadian clock phase-resetting in the mouse.

Authors:  Allison J Brager; Christina L Ruby; Rebecca A Prosser; J David Glass
Journal:  Alcohol Clin Exp Res       Date:  2011-04-04       Impact factor: 3.455

4.  Effects of isoflurane and ethanol administration on c-Fos immunoreactivity in mice.

Authors:  M L Smith; J Li; D M Cote; A E Ryabinin
Journal:  Neuroscience       Date:  2015-12-29       Impact factor: 3.590

5.  Cerebral activity during the anesthesia-like state induced by mesopontine microinjection of pentobarbital.

Authors:  Ruth Abulafia; Vladimir Zalkind; Marshall Devor
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

6.  FOS expression induced by an ethanol-paired conditioned stimulus.

Authors:  Katherine G Hill; Andrey E Ryabinin; Christopher L Cunningham
Journal:  Pharmacol Biochem Behav       Date:  2007-05-04       Impact factor: 3.533

7.  Cocaine-induced Fos expression is detectable in the frontal cortex and striatum of rats under isoflurane but not alpha-chloralose anesthesia: implications for FMRI.

Authors:  Peter R Kufahl; Nathan S Pentkowski; Krista Heintzelman; Janet L Neisewander
Journal:  J Neurosci Methods       Date:  2009-05-23       Impact factor: 2.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.